Endocrine-related effects of perfluorooctanoic acid (PFOA) in zebrafish, H295R steroidogenesis and receptor reporter gene assays

Chemosphere

Volumn 91, Issue 8, 2013, Pages 1099-1106

  Du, Guizhen ^a,b   Huang, Hongyu ^a,b   Hu, Jialei ^a,b   Qin, Yufeng ^a,b   Wu, Di ^a,b   Song, Ling ^a,b   Xia, Yankai ^a,b   Wang, Xinru ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

Author keywords

Endocrine disrupting effect; H295R steroidogenesis assay; Perfluorooctanoic acid (PFOA); Reporter gene assay; SF 1; Zebrafish embryos

Indexed keywords

ENDOCRINE DISRUPTERS; ENDOCRINOLOGY; GENE EXPRESSION;

ENDOCRINE-DISRUPTING EFFECT; PERFLUOROOCTANOIC ACID; REPORTER GENE ASSAYS; SF-1; ZEBRAFISH EMBRYOS;

RISK ASSESSMENT;

ANDROGEN RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; PERFLUOROOCTANOIC ACID; STEROIDOGENIC FACTOR 1; TESTOSTERONE;

CYPRINID; EMBRYO; ENDOCRINE DISRUPTOR; GENE EXPRESSION; HORMONE; ORGANIC POLLUTANT; POLLUTION EXPOSURE; PUBLIC HEALTH; RISK ASSESSMENT; STEROID;

ARTICLE; CELL ASSAY; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; ESR1 GENE; EXPOSURE; GENE; GENE EXPRESSION; HEALTH HAZARD; HHEX GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PAX GENE; REGULATOR GENE; REPORTER GENE; RISK ASSESSMENT; STEROIDOGENESIS; ZEBRA FISH;

DANIO RERIO;

ANIMALS; BIOLOGICAL ASSAY; CAPRYLATES; CELL LINE; ENDOCRINE DISRUPTORS; ENDOCRINE SYSTEM; ESTRADIOL; FLUOROCARBONS; GENES, REPORTER; TESTOSTERONE; WATER POLLUTANTS, CHEMICAL; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84876323389     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.01.012     Document Type: Article

References (54)

1. Bakke M., Zhao L., Hanley N.A., Parker K.L. SF-1: a critical mediator of steroidogenesis. Mol. Cell Endocrinol. 2001, 171:5-7.
2. Benninghoff A.D., Bisson W.H., Koch D.C., Ehresman D.J., Kolluri S.K., Williams D.E. Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro. Toxicol. Sci. 2011, 120:42-58.
3. Beuschlein F., Keegan C.E., Bavers D.L., Mutch C., Hutz J.E., Shah S., Ulrich-Lai Y.M., Engeland W.C., Jeffs B., Jameson J.L., Hammer G.D. SF-1, DAX-1, and acd: molecular determinants of adrenocortical growth andsteroidogenesis. Endocr. Res. 2002, 28:597-607.
4. Butenhoff J., Costa G., Elcombe C., Farrar D., Hansen K., Iwai H., Jung R., Kennedy G., Lieder P., Olsen G., Thomford P. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6months. Toxicol. Sci. 2002, 69:244-257.
5. Chandrasekar G., Archer A., Gustafsson J.A., Andersson Lendahl M. Levels of 17beta-estradiol receptors expressed in embryonic and adult zebrafish following in vivo treatment of natural or synthetic ligands. PLoS One 2010, 5:e9678.
6. D'Hollander W., de Voogt P., De Coen W., Bervoets L. Perfluorinated substances in human food and other sources of human exposure. Rev. Environ. Contam. Toxicol. 2010, 208:179-215.
7. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., Zoeller R.T., Gore A.C. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev. 2009, 30:293-342.
8. Du G., Shen O., Sun H., Fei J., Lu C., Song L., Xia Y., Wang S., Wang X. Assessing hormone receptor activities of pyrethroid insecticides and their metabolites in reporter gene assays. Toxicol. Sci. 2010, 116:58-66.
9. Ehrlund A., Anthonisen E.H., Gustafsson N., Venteclef N., Robertson Remen K., Damdimopoulos A.E., Galeeva A., Pelto-Huikko M., Lalli E., Steffensen K.R., Gustafsson J.A., Treuter E. E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis. Mol. Cell Biol. 2009, 29:2230-2242.
10. Ehrlund A., Jonsson P., Vedin L.L., Williams C., Gustafsson J.Å., Treuter E. Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells. PLoS One 2012, 7(3):e32080.
11. Elsalini O.A., von Gartzen J., Cramer M., Rohr K.B. Zebrafish hhex, nk2.1a and pax2.1 regulate thyroid growth and differentiation downstream of nodal-dependent transcription factors. Dev. Biol. 2003, 263:67-80.
12. Fromme H., Schlummer M., Möller A., Gruber L., Wolz G., Ungewiss J., Böhmer S., Dekant W., Mayer R., Liebl B., Twardella D. Exposure of an adult population to perfluorinated substances using duplicate diet portions and biomonitoring data. Environ. Sci. Technol. 2007, 41:7928-7933.
13. Fromme H., Tittlemier S.A., Völkel W., Wilhelm M., Twardella D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 2009, 212:239-270.
14. Giesy J.P., Kannan K. Perfluorochemical surfactants in the environment. Environ. Sci. Technol. 2002, 36:146A-152A.
15. Guruge K.S., Yeung L.W., Yamanaka N., Miyazaki S., Lam P.K., Giesy J.P., Jones P.D., Yamashita N. Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA). Toxicol. Sci. 2006, 89:93-107.
16. Hagenaars A., Vergauwen L., De Coen W., Knapen D. Structure-activity relationship assessment of four perfluorinated chemicals using a prolonged zebrafish early life stage test. Chemosphere 2011, 82:764-772.
17. Henry N.D., Fair P.A. Comparison of in vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid. J. Appl. Toxicol. 2011, 10.1002/jat.1736.
18. Hilscherova K., Jones P.D., Gracia T., Newsted J.L., Zhang X., Sanderson J.T., Yu R.M., Wu R.S., Giesy J.P. Assessment of the effects of chemicals on the expression of ten steroidogenic genes in the H295R cell line using real-time PCR. Toxicol. Sci. 2004, 81:78-89.
19. Hoffman K., Webster T.F., Bartell S.M., Weisskopf M.G., Fletcher T., Vieira V.M. Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility. Environ. Health Perspect. 2011, 119:92-97.
20. Hu M.C., Hsu N.C., Pai C.I., Wang C.K., Chung B. Functions of the upstream and proximal steroidogenic factor 1 (SF-1)-binding sites in the CYP11A1 promoter in basal transcription and hormonal response. Mol. Endocrinol. 2001, 15:812-818.
21. Joensen U.N., Bossi R., Leffers H., Jensen A.A., Skakkebaek N.E., Jørgensen N. Do perfluoroalkyl compounds impair human semen quality?. Environ. Health Perspect. 2009, 117:923-927.
22. Kraugerud M., Zimmer K.E., Ropstad E., Verhaegen S. Perfluorinated compounds differentially affect steroidogenesis and viability in the human adrenocortical carcinoma (H295R) in vitro cell assay. Toxicol. Lett. 2011, 205:62-68.
23. Kunacheva C., Fujii S., Tanaka S., Seneviratne S.T., Lien N.P., Nozoe M., Kimura K., Shivakoti B.R., Harada H. Worldwide surveys of perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) in water environment in recent years. Water Sci. Technol. 2012, 66:2764-2771.
24. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., Butenhoff J.L., Stevenson L.A. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol. Sci. 2003, 74:382-392.
25. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
26. Li L.A. Polychlorinated biphenyl exposure and CYP19 gene regulation in testicular and adrenocortical cell lines. Toxicol. in Vitro 2007, 21:1087-1094.
27. Lindstrom A.B., Strynar M.J., Libelo E.L. Polyfluorinated compounds: past, present, and future. Environ. Sci. Technol. 2011, 45:7954-7961.
28. Liu C., Du Y., Zhou B. Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes. Aquat. Toxicol. 2007, 86:267-277.
29. Liu Y., Wang J., Wei Y., Zhang H., Liu Y., Dai J. Molecular characterization of cytochrome P450 1A and 3A and the effects of perfluorooctanoic acid on their mRNA levels in rare minnow (Gobiocypris rarus) gills. Aquat. Toxicol. 2008, 88:183-190.
30. Liu C., Zhang X., Chang H., Jones P., Wiseman S., Naile J., Hecker M., Giesy J.P., Zhou B. Effects of fluorotelomer alcohol 8:2 FTOH on steroidogenesis in H295R cells: targeting the cAMP signalling cascade. Toxicol. Appl. Pharmacol. 2010, 247:222-228.
31. Maras M., Vanparys C., Muylle F., Robbens J., Berger U., Barber J.L., Blust R., De Coen W. Estrogen-like properties of fluorotelomer alcohols as revealed by MCF-7 breast cancer cell proliferation. Environ. Health Perspect. 2006, 114:100-105.
32. Martin M.T., Brennan R.J., Hu W., Ayanoglu E., Lau C., Ren H., Wood C.R., Corton J.C., Kavlock R.J., Dix D.J. Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity. Toxicol. Sci. 2007, 97:595-613.
33. Melzer D., Rice N., Depledge M.H., Henley W.E., Galloway T.S. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ. Health Perspect. 2010, 118:686-692.
34. Menuet A., Pellegrini E., Anglade I., Blaise O., Laudet V., Kah O., Pakdel F. Molecular characterization of three estrogen receptor forms in zebrafish: binding characteristics, transactivation properties, and tissue distributions. Biol. Reprod. 2002, 66:1881-1892.
35. Moody C.A., Hebert G.N., Strauss S.H., Field J.A. Occurrence and persistence of perfluorooctanesulfonate and other perfluorinated surfactants in groundwater at a fire-training area at Wurtsmith Air Force Base, Michigan, USA. J. Environ. Monit. 2003, 5:341-345.
36. Olsen G.W., Gilliland F.D., Burlew M.M., Burris J.M., Mandel J.S., Mandel J.H. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J. Occup. Environ. Med. 1998, 40:614-622.
37. Olsen G.W., Burris J.M., Burlew M.M., Mandel J.H. Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem. Toxicol. 2000, 23:603-620.
38. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., Zobel L.R. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115:1298-1305.
39. Olsen G.W., Butenhoff J.L., Zobel L.R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod. Toxicol. 2009, 27:212-230.
40. Prevedouros K., Cousins I.T., Buck R.C., Korzeniowski S.H. Sources, fate and transport of perfluorocarboxylates. Environ. Sci. Technol. 2006, 40:32-44.
41. Renner R. Growing concern over perfluorinated chemicals. Environ. Sci. Technol. 2001, 35:154-160.
42. Rosen M.B., Lee J.S., Ren H., Vallanat B., Liu J., Waalkes M.P., Abbott B.D., Lau C., Corton J.C. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR. Toxicol. Sci. 2008, 103:46-56.
43. Sakr C.J., Kreckmann K.H., Green J.W., Gillies P.J., Reynolds J.L., Leonard R.C. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J. Occup. Environ. Med. 2007, 49:1086-1096.
44. Schmutzler C., Gotthardt I., Hofmann P.J., Radovic B., Kovacs G., Stemmler L., Nobis I., Bacinski A., Mentrup B., Ambrugger P., Grüters A., Malendowicz L.K., Christoffel J., Jarry H., Seidlovà-Wuttke D., Wuttke W., Köhrle J. Endocrine disruptors and the thyroid gland - a combined in vitro and in vivo analysis of potential new biomarkers. Environ. Health Perspect. 2007, 115:77-83.
45. Shi X., Du Y., Lam P.K., Wu R.S., Zhou B. Developmental toxicity and alteration of gene expression in zebrafish embryos exposed to PFOS. Toxicol. Appl. Pharmacol. 2008, 230:23-32.
46. Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Barbee B.D., Richards J.H., Butenhoff J.L., Stevenson L.A., Lau C. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol. Sci. 2003, 74:369-381.
47. Vestergren R., Cousins I.T. Tracking the pathways of human exposure to perfluorocarboxylates. Environ. Sci. Technol. 2009, 43:5565-5575.
48. Weiss J.M., Andersson P.L., Lamoree M.H., Leonards P.E., van Leeuwen S.P., Hamers T. Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin. Toxicol. Sci. 2009, 109:206-216.
49. Wendl T., Lun K., Mione M., Favor J., Brand M., Wilson S.W., Rohr K.B. Pax2.1 is required for the development of thyroid follicles in zebrafish. Development 2002, 129:3751-3760.
50. Wolf D.C., Moore T., Abbott B.D., Rosen M.B., Das K.P., Zehr R.D., Lindstrom A.B., Strynar M.J., Lau C. Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice. Toxicol. Pathol. 2008, 36:632-639.
51. Zhang T., Sun H.W., Wu Q., Zhang X.Z., Yun S.H., Kannan K. Perfluorochemicals in meat, eggs and indoor dust in China: assessment of sources and pathways of humanexposure to perfluorochemicals. Environ. Sci. Technol. 2010, 44:3572-3579.
52. Zhang T., Sun H., Lin Y., Wang L., Zhang X., Liu Y., Geng X., Zhao L., Li F., Kannan K. Perfluorinated compounds in human blood, water, edible freshwater fish, and seafood in China: daily intake and regional differences in human exposures. J. Agric. Food Chem. 2011, 59:11168-11176.
53. Zhao B., Chu Y., Hardy D.O., Li X.K., Ge R.S. Inhibition of 3beta- and 17beta-hydroxysteroid dehydrogenase activities in rat Leydig cells by perfluorooctane acid. J. Steroid Biochem. Mol. Biol. 2010, 118:13-17.
54. Zhao Y., Tan Y.S., Haslam S.Z., Yang C. Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57Bl/6 mice. Toxicol. Sci. 2010, 115:214-224.